S&P 500   4,397.94 (-1.89%)
DOW   34,265.37 (-1.30%)
QQQ   351.69 (-2.77%)
AAPL   162.41 (-1.28%)
MSFT   296.03 (-1.85%)
FB   303.17 (-4.23%)
GOOGL   2,607.03 (-2.22%)
AMZN   2,852.86 (-5.95%)
TSLA   943.90 (-5.26%)
NVDA   233.74 (-3.21%)
BABA   123.23 (-5.95%)
NIO   27.35 (-6.11%)
AMD   118.81 (-2.53%)
CGC   7.29 (-3.57%)
MU   81.93 (-3.69%)
GE   96.30 (-1.98%)
T   26.61 (-1.52%)
F   20.65 (-4.62%)
DIS   137.38 (-6.94%)
AMC   17.97 (-0.55%)
PFE   52.79 (-2.33%)
ACB   4.46 (-6.11%)
BA   205.44 (-4.09%)
S&P 500   4,397.94 (-1.89%)
DOW   34,265.37 (-1.30%)
QQQ   351.69 (-2.77%)
AAPL   162.41 (-1.28%)
MSFT   296.03 (-1.85%)
FB   303.17 (-4.23%)
GOOGL   2,607.03 (-2.22%)
AMZN   2,852.86 (-5.95%)
TSLA   943.90 (-5.26%)
NVDA   233.74 (-3.21%)
BABA   123.23 (-5.95%)
NIO   27.35 (-6.11%)
AMD   118.81 (-2.53%)
CGC   7.29 (-3.57%)
MU   81.93 (-3.69%)
GE   96.30 (-1.98%)
T   26.61 (-1.52%)
F   20.65 (-4.62%)
DIS   137.38 (-6.94%)
AMC   17.97 (-0.55%)
PFE   52.79 (-2.33%)
ACB   4.46 (-6.11%)
BA   205.44 (-4.09%)
S&P 500   4,397.94 (-1.89%)
DOW   34,265.37 (-1.30%)
QQQ   351.69 (-2.77%)
AAPL   162.41 (-1.28%)
MSFT   296.03 (-1.85%)
FB   303.17 (-4.23%)
GOOGL   2,607.03 (-2.22%)
AMZN   2,852.86 (-5.95%)
TSLA   943.90 (-5.26%)
NVDA   233.74 (-3.21%)
BABA   123.23 (-5.95%)
NIO   27.35 (-6.11%)
AMD   118.81 (-2.53%)
CGC   7.29 (-3.57%)
MU   81.93 (-3.69%)
GE   96.30 (-1.98%)
T   26.61 (-1.52%)
F   20.65 (-4.62%)
DIS   137.38 (-6.94%)
AMC   17.97 (-0.55%)
PFE   52.79 (-2.33%)
ACB   4.46 (-6.11%)
BA   205.44 (-4.09%)
S&P 500   4,397.94 (-1.89%)
DOW   34,265.37 (-1.30%)
QQQ   351.69 (-2.77%)
AAPL   162.41 (-1.28%)
MSFT   296.03 (-1.85%)
FB   303.17 (-4.23%)
GOOGL   2,607.03 (-2.22%)
AMZN   2,852.86 (-5.95%)
TSLA   943.90 (-5.26%)
NVDA   233.74 (-3.21%)
BABA   123.23 (-5.95%)
NIO   27.35 (-6.11%)
AMD   118.81 (-2.53%)
CGC   7.29 (-3.57%)
MU   81.93 (-3.69%)
GE   96.30 (-1.98%)
T   26.61 (-1.52%)
F   20.65 (-4.62%)
DIS   137.38 (-6.94%)
AMC   17.97 (-0.55%)
PFE   52.79 (-2.33%)
ACB   4.46 (-6.11%)
BA   205.44 (-4.09%)
NASDAQ:ANIX

Anixa Biosciences News Headlines

$3.10
-0.10 (-3.13%)
(As of 01/21/2022 04:00 PM ET)
Add
Compare
Today's Range
$3.03
$3.27
50-Day Range
$2.78
$4.55
52-Week Range
$2.71
$8.09
Volume
86,477 shs
Average Volume
123,222 shs
Market Capitalization
$93.41 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.65
Get Anixa Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for ANIX and its competitors with MarketBeat's FREE daily newsletter.

Media Mentions By Week

Anixa Biosciences Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ANIX
News Sentiment

0.00

0.41

Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ANIX Articles
This Week

0

1

ANIX Articles
Average Week



Anixa Biosciences (NASDAQ:ANIX) News Headlines Today

SourceHeadline
insidertrades.com logoAnixa Biosciences, Inc. (NASDAQ:ANIX) Director Lewis H. Titterton, Jr. Buys 11,000 Shares
insidertrades.com - January 10 at 12:28 PM
insidertrades.com logoAmit Kumar Buys 20,000 Shares of Anixa Biosciences, Inc. (NASDAQ:ANIX) Stock
insidertrades.com - January 7 at 2:34 PM
nasdaq.com logoAnixa Biosciences Inc Shares Close in on 52-Week Low - Market Mover
nasdaq.com - January 6 at 8:08 AM
finance.yahoo.com logoAnixa Biosciences to Participate in Upcoming January Investor Conferences: LifeSci Partners Annual Corporate Access Event and H.C. Wainwright BioConnect Conference
finance.yahoo.com - December 16 at 9:32 AM
benzinga.com logoAnixa Biosciences, MolGenie Report Their COVID-19 Compounds Expected To Be Effective Against Omicron Variant
benzinga.com - December 7 at 2:31 PM
markets.businessinsider.com logoAnixa : COVID-19 Compounds Expected To Be Effective Against Omicron And Delta Variants
markets.businessinsider.com - December 7 at 10:08 AM
finance.yahoo.com logoAnixa Biosciences and MolGenie Announce that their COVID-19 Compounds are Expected to be Effective Against the Omicron Variant
finance.yahoo.com - December 7 at 9:30 AM
nasdaq.com logoThe First Human Trial of a Prevenative Breast Cancer Vaccine
nasdaq.com - October 28 at 6:55 PM
msn.com logoTrial launched for first-ever vaccine to prevent breast cancer
msn.com - October 27 at 3:15 PM
msn.com logoCleveland Clinic begins new clinical trial for vaccine aimed at stopping aggressive breast cancer
msn.com - October 26 at 9:47 AM
finance.yahoo.com logoAnixa Biosciences Announces Patient Dosing of its Investigational Vaccine Candidate in a First-of-its-Kind Preventative Breast Cancer Vaccine Study
finance.yahoo.com - October 26 at 9:47 AM
finance.yahoo.com logoAnixa Biosciences Announces First Chinese Patent on its CAR-T Cancer Therapy Technology
finance.yahoo.com - October 6 at 1:02 PM
finance.yahoo.com logoAnixa Biosciences Announces Notice of Allowance for Additional Patent on its CAR-T Cancer Therapy
finance.yahoo.com - October 1 at 11:55 AM
finance.yahoo.com logoAnixa Biosciences' Ovarian Cancer CAR-T Therapy to be Discussed at Upcoming Emerging Immunotherapeutics for Ovarian Cancer Symposium
finance.yahoo.com - September 14 at 10:25 AM
finance.yahoo.com logoAnixa Biosciences to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
finance.yahoo.com - September 8 at 8:47 AM
finance.yahoo.com logoAnixa Biosciences Appoints Dr. Pamela Garzone As Chief Development Officer
finance.yahoo.com - September 7 at 12:51 PM
finance.yahoo.com logoAnixa (ANIX) Ovarian Cancer CAR-T Drug to Enter Clinical Study
finance.yahoo.com - August 31 at 5:00 PM
msn.com logoBRIEF-Anixa Biosciences Gets FDA Clearance For Ovarian Cancer Trial
msn.com - August 30 at 3:57 PM
nasdaq.com logoAnixa Biosciences Says FDA Clears IND For CAR-T Immunotherapy For Ovarian Cancer - Quick Facts
nasdaq.com - August 30 at 3:57 PM
marketwatch.com logoAnixa Biosciences Shares Rise 5% After FDA Approves Cancer Therapy
marketwatch.com - August 30 at 3:57 PM
finance.yahoo.com logoAnixa Biosciences and Moffitt Cancer Center Announce FDA Clearance to Initiate Clinical Trial of Ovarian Cancer CAR-T Immunotherapy
finance.yahoo.com - August 30 at 3:57 PM
finance.yahoo.com logoAnixa Biosciences' COVID-19 Compounds Show Potential Efficacy Against Delta Variant
finance.yahoo.com - August 25 at 9:39 PM
nasdaq.com logoAnixa: Theoretical Study Shows Effectiveness Of Its Compounds Against Delta Variant
nasdaq.com - August 25 at 4:39 PM
marketwatch.com logoAnixa Biosciences Shares Rise 10% on Possible Covid-19 Treatment
marketwatch.com - August 25 at 4:39 PM
finance.yahoo.com logoAnixa Biosciences Congratulates Director, Dr. Arnold Baskies for His Appointment to the WHO's Global Breast Cancer Initiative
finance.yahoo.com - August 23 at 2:55 PM
marketwatch.com logoAnixa Biosciences Shares Rise 10% After Patent for Ovarian Cancer Vaccine Technology
marketwatch.com - August 18 at 4:57 PM
finance.yahoo.com logoAnixa Biosciences Announces Issuance of U.S. Patent for Ovarian Cancer Vaccine Technology
finance.yahoo.com - August 18 at 4:57 PM
nasdaq.com logoFriday 7/16 Insider Buying Report: ANIX, MGYR
nasdaq.com - July 16 at 4:55 PM
nasdaq.com logoAnixa Biosciences, Inc. Common Stock (ANIX)
nasdaq.com - June 27 at 7:18 PM
nasdaq.com logoWe're Interested To See How Anixa Biosciences (NASDAQ:ANIX) Uses Its Cash Hoard To Grow
nasdaq.com - June 12 at 10:43 AM
finance.yahoo.com logoHere's Why We're Not At All Concerned With Anixa Biosciences' (NASDAQ:ANIX) Cash Burn Situation
finance.yahoo.com - June 12 at 10:43 AM
finance.yahoo.com logoAnixa Biosciences Announces Support from the National Cancer Institute for Ovarian Cancer Vaccine Developed by Cleveland Clinic
finance.yahoo.com - May 26 at 10:06 AM
marketwatch.com logoAnixa: Gets Additional Information Request from FDA for CAR-T IND Application
marketwatch.com - May 20 at 1:21 PM
nasdaq.com logoAnixa Biosciences Receives Addl Information Request From FDA For CAR-T IND Application
nasdaq.com - May 20 at 1:21 PM
finance.yahoo.com logoAnixa Biosciences and Moffitt Cancer Center Receive Additional Information Request from US FDA for CAR-T IND Application
finance.yahoo.com - May 20 at 9:23 AM
finance.yahoo.com logoOntoChem Assigns Anixa Covid-19 Drug Discovery Project to MolGenie
finance.yahoo.com - May 7 at 8:55 AM
finance.yahoo.com logoBiotech Stock Roundup: BMYs Opdivo Gets FDA Nod for Gastric Cancer & Other Updates
finance.yahoo.com - April 21 at 5:52 PM
msn.com logoBRIEF-Anixa Biosciences And Moffitt Cancer Center Report U.S. FDA Request Of Additional Information For Car-T Therapy
msn.com - April 20 at 10:04 AM
finance.yahoo.com logoAnixa's Stock Craters As FDA Slaps Clinical Hold On CAR-T Program
finance.yahoo.com - April 19 at 6:17 PM
nasdaq.com logoAnixa Biosciences: FDA Asks Addl Information For CAR-T Therapy; Stock Plunges
nasdaq.com - April 19 at 1:17 PM
finance.yahoo.com logoAnixa Biosciences and Moffitt Cancer Center Report US FDA Request of Additional Information for CAR-T Therapy
finance.yahoo.com - April 19 at 1:17 PM
finance.yahoo.com logoInvesting in These 2 Stocks Could Double Your Money, Say Analysts
finance.yahoo.com - April 14 at 11:33 PM
finance.yahoo.com logoAnixa Biosciences and OntoChem Enter Next Stage of Development for Covid-19 Therapeutic
finance.yahoo.com - April 5 at 12:36 PM
finance.yahoo.com logoAnixa Biosciences Stock Gives Every Indication Of Being Significantly Overvalued
finance.yahoo.com - March 28 at 1:09 PM
finance.yahoo.com logoAnixa Biosciences Stock Is Estimated To Be Significantly Overvalued
finance.yahoo.com - March 27 at 2:49 PM
benzinga.com logoAnixa Biosciences Prices ~1.9M Share Common Stock Offering At $5.25/Share
benzinga.com - March 22 at 11:12 PM
finance.yahoo.com logoAnixa Biosciences Announces $10 Million Bought Deal Offering of Common Stock
finance.yahoo.com - March 22 at 6:11 PM
finance.yahoo.com logoAnixa Biosciences and Moffitt Cancer Center File IND Application for Ovarian Cancer CAR-T Therapy
finance.yahoo.com - March 22 at 9:22 AM
finance.yahoo.com logoAnixa Biosciences Announces Issuance and Publication of European Patent for Ovarian Cancer Vaccine Technology
finance.yahoo.com - March 12 at 11:24 AM
finance.yahoo.com logoAnixa Biosciences Announces European Patent Issued for its CAR-T Cancer Therapy
finance.yahoo.com - March 4 at 9:30 AM
Get Anixa Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for ANIX and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 1/21/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.